X-101397753-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001199973.2(RPL36A-HNRNPH2):c.300+2296A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00056 in 1,051,302 control chromosomes in the GnomAD database, including 1 homozygotes. There are 158 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.00060 ( 1 hom. 153 hem. )
Consequence
RPL36A-HNRNPH2
NM_001199973.2 intron
NM_001199973.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.07
Genes affected
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant X-101397753-A-C is Benign according to our data. Variant chrX-101397753-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 3048387.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPL36A-HNRNPH2 | NM_001199973.2 | c.300+2296A>C | intron_variant | ||||
GLA | NM_000169.3 | downstream_gene_variant | ENST00000218516.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLA | ENST00000218516.4 | downstream_gene_variant | 1 | NM_000169.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000222 AC: 25AN: 112752Hom.: 0 Cov.: 23 AF XY: 0.000143 AC XY: 5AN XY: 34912
GnomAD3 genomes
AF:
AC:
25
AN:
112752
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34912
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000601 AC: 564AN: 938496Hom.: 1 Cov.: 17 AF XY: 0.000569 AC XY: 153AN XY: 268802
GnomAD4 exome
AF:
AC:
564
AN:
938496
Hom.:
Cov.:
17
AF XY:
AC XY:
153
AN XY:
268802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000222 AC: 25AN: 112806Hom.: 0 Cov.: 23 AF XY: 0.000143 AC XY: 5AN XY: 34976
GnomAD4 genome
AF:
AC:
25
AN:
112806
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34976
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GLA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 27, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at